Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial

In this placebo-controlled trial, 10/13 malaria naïve subjects immunized with a simplified regimen of chemoattenuated P. falciparum sporozoites, PfSPZ-CVac, show sterile protection from heterologous malaria challenge. Immunization was well tolerated and induced high levels of anti-PfCSP antibodies.

Bibliographic Details
Main Authors: Zita Sulyok, Rolf Fendel, Bianca Eder, Freia-Raphaella Lorenz, Natasha KC, Matthias Karnahl, Albert Lalremruata, The T. Nguyen, Jana Held, Folashade Almeine Cyntiche Adjadi, Torsten Klockenbring, Judith Flügge, Tamirat Gebru Woldearegai, Carlos Lamsfus Calle, Javier Ibáñez, Miriam Rodi, Diane Egger-Adam, Andrea Kreidenweiss, Carsten Köhler, Meral Esen, Mihály Sulyok, Anita Manoj, Thomas L. Richie, B. Kim Lee Sim, Stephen L. Hoffman, Benjamin Mordmüller, Peter G. Kremsner
Format: Article
Language:English
Published: Nature Publishing Group 2021-05-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-021-22740-w
id doaj-de6161831021472293648f15342062a5
record_format Article
spelling doaj-de6161831021472293648f15342062a52021-05-09T11:12:25ZengNature Publishing GroupNature Communications2041-17232021-05-0112111010.1038/s41467-021-22740-wHeterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trialZita Sulyok0Rolf Fendel1Bianca Eder2Freia-Raphaella Lorenz3Natasha KC4Matthias Karnahl5Albert Lalremruata6The T. Nguyen7Jana Held8Folashade Almeine Cyntiche Adjadi9Torsten Klockenbring10Judith Flügge11Tamirat Gebru Woldearegai12Carlos Lamsfus Calle13Javier Ibáñez14Miriam Rodi15Diane Egger-Adam16Andrea Kreidenweiss17Carsten Köhler18Meral Esen19Mihály Sulyok20Anita Manoj21Thomas L. Richie22B. Kim Lee Sim23Stephen L. Hoffman24Benjamin Mordmüller25Peter G. Kremsner26Institute of Tropical Medicine, University and University Hospital of TübingenInstitute of Tropical Medicine, University and University Hospital of TübingenInstitute of Tropical Medicine, University and University Hospital of TübingenInstitute of Tropical Medicine, University and University Hospital of TübingenSanaria IncInstitute of Tropical Medicine, University and University Hospital of TübingenInstitute of Tropical Medicine, University and University Hospital of TübingenInstitute of Tropical Medicine, University and University Hospital of TübingenInstitute of Tropical Medicine, University and University Hospital of TübingenInstitute of Tropical Medicine, University and University Hospital of TübingenFraunhofer Institute of Molecular Biology and Applied Ecology IMEInstitute of Tropical Medicine, University and University Hospital of TübingenInstitute of Tropical Medicine, University and University Hospital of TübingenInstitute of Tropical Medicine, University and University Hospital of TübingenInstitute of Tropical Medicine, University and University Hospital of TübingenInstitute of Tropical Medicine, University and University Hospital of TübingenInstitute of Tropical Medicine, University and University Hospital of TübingenInstitute of Tropical Medicine, University and University Hospital of TübingenInstitute of Tropical Medicine, University and University Hospital of TübingenInstitute of Tropical Medicine, University and University Hospital of TübingenInstitute of Tropical Medicine, University and University Hospital of TübingenSanaria IncSanaria IncSanaria IncSanaria IncInstitute of Tropical Medicine, University and University Hospital of TübingenInstitute of Tropical Medicine, University and University Hospital of TübingenIn this placebo-controlled trial, 10/13 malaria naïve subjects immunized with a simplified regimen of chemoattenuated P. falciparum sporozoites, PfSPZ-CVac, show sterile protection from heterologous malaria challenge. Immunization was well tolerated and induced high levels of anti-PfCSP antibodies.https://doi.org/10.1038/s41467-021-22740-w
collection DOAJ
language English
format Article
sources DOAJ
author Zita Sulyok
Rolf Fendel
Bianca Eder
Freia-Raphaella Lorenz
Natasha KC
Matthias Karnahl
Albert Lalremruata
The T. Nguyen
Jana Held
Folashade Almeine Cyntiche Adjadi
Torsten Klockenbring
Judith Flügge
Tamirat Gebru Woldearegai
Carlos Lamsfus Calle
Javier Ibáñez
Miriam Rodi
Diane Egger-Adam
Andrea Kreidenweiss
Carsten Köhler
Meral Esen
Mihály Sulyok
Anita Manoj
Thomas L. Richie
B. Kim Lee Sim
Stephen L. Hoffman
Benjamin Mordmüller
Peter G. Kremsner
spellingShingle Zita Sulyok
Rolf Fendel
Bianca Eder
Freia-Raphaella Lorenz
Natasha KC
Matthias Karnahl
Albert Lalremruata
The T. Nguyen
Jana Held
Folashade Almeine Cyntiche Adjadi
Torsten Klockenbring
Judith Flügge
Tamirat Gebru Woldearegai
Carlos Lamsfus Calle
Javier Ibáñez
Miriam Rodi
Diane Egger-Adam
Andrea Kreidenweiss
Carsten Köhler
Meral Esen
Mihály Sulyok
Anita Manoj
Thomas L. Richie
B. Kim Lee Sim
Stephen L. Hoffman
Benjamin Mordmüller
Peter G. Kremsner
Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial
Nature Communications
author_facet Zita Sulyok
Rolf Fendel
Bianca Eder
Freia-Raphaella Lorenz
Natasha KC
Matthias Karnahl
Albert Lalremruata
The T. Nguyen
Jana Held
Folashade Almeine Cyntiche Adjadi
Torsten Klockenbring
Judith Flügge
Tamirat Gebru Woldearegai
Carlos Lamsfus Calle
Javier Ibáñez
Miriam Rodi
Diane Egger-Adam
Andrea Kreidenweiss
Carsten Köhler
Meral Esen
Mihály Sulyok
Anita Manoj
Thomas L. Richie
B. Kim Lee Sim
Stephen L. Hoffman
Benjamin Mordmüller
Peter G. Kremsner
author_sort Zita Sulyok
title Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial
title_short Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial
title_full Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial
title_fullStr Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial
title_full_unstemmed Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial
title_sort heterologous protection against malaria by a simple chemoattenuated pfspz vaccine regimen in a randomized trial
publisher Nature Publishing Group
series Nature Communications
issn 2041-1723
publishDate 2021-05-01
description In this placebo-controlled trial, 10/13 malaria naïve subjects immunized with a simplified regimen of chemoattenuated P. falciparum sporozoites, PfSPZ-CVac, show sterile protection from heterologous malaria challenge. Immunization was well tolerated and induced high levels of anti-PfCSP antibodies.
url https://doi.org/10.1038/s41467-021-22740-w
work_keys_str_mv AT zitasulyok heterologousprotectionagainstmalariabyasimplechemoattenuatedpfspzvaccineregimeninarandomizedtrial
AT rolffendel heterologousprotectionagainstmalariabyasimplechemoattenuatedpfspzvaccineregimeninarandomizedtrial
AT biancaeder heterologousprotectionagainstmalariabyasimplechemoattenuatedpfspzvaccineregimeninarandomizedtrial
AT freiaraphaellalorenz heterologousprotectionagainstmalariabyasimplechemoattenuatedpfspzvaccineregimeninarandomizedtrial
AT natashakc heterologousprotectionagainstmalariabyasimplechemoattenuatedpfspzvaccineregimeninarandomizedtrial
AT matthiaskarnahl heterologousprotectionagainstmalariabyasimplechemoattenuatedpfspzvaccineregimeninarandomizedtrial
AT albertlalremruata heterologousprotectionagainstmalariabyasimplechemoattenuatedpfspzvaccineregimeninarandomizedtrial
AT thetnguyen heterologousprotectionagainstmalariabyasimplechemoattenuatedpfspzvaccineregimeninarandomizedtrial
AT janaheld heterologousprotectionagainstmalariabyasimplechemoattenuatedpfspzvaccineregimeninarandomizedtrial
AT folashadealmeinecynticheadjadi heterologousprotectionagainstmalariabyasimplechemoattenuatedpfspzvaccineregimeninarandomizedtrial
AT torstenklockenbring heterologousprotectionagainstmalariabyasimplechemoattenuatedpfspzvaccineregimeninarandomizedtrial
AT judithflugge heterologousprotectionagainstmalariabyasimplechemoattenuatedpfspzvaccineregimeninarandomizedtrial
AT tamiratgebruwoldearegai heterologousprotectionagainstmalariabyasimplechemoattenuatedpfspzvaccineregimeninarandomizedtrial
AT carloslamsfuscalle heterologousprotectionagainstmalariabyasimplechemoattenuatedpfspzvaccineregimeninarandomizedtrial
AT javieribanez heterologousprotectionagainstmalariabyasimplechemoattenuatedpfspzvaccineregimeninarandomizedtrial
AT miriamrodi heterologousprotectionagainstmalariabyasimplechemoattenuatedpfspzvaccineregimeninarandomizedtrial
AT dianeeggeradam heterologousprotectionagainstmalariabyasimplechemoattenuatedpfspzvaccineregimeninarandomizedtrial
AT andreakreidenweiss heterologousprotectionagainstmalariabyasimplechemoattenuatedpfspzvaccineregimeninarandomizedtrial
AT carstenkohler heterologousprotectionagainstmalariabyasimplechemoattenuatedpfspzvaccineregimeninarandomizedtrial
AT meralesen heterologousprotectionagainstmalariabyasimplechemoattenuatedpfspzvaccineregimeninarandomizedtrial
AT mihalysulyok heterologousprotectionagainstmalariabyasimplechemoattenuatedpfspzvaccineregimeninarandomizedtrial
AT anitamanoj heterologousprotectionagainstmalariabyasimplechemoattenuatedpfspzvaccineregimeninarandomizedtrial
AT thomaslrichie heterologousprotectionagainstmalariabyasimplechemoattenuatedpfspzvaccineregimeninarandomizedtrial
AT bkimleesim heterologousprotectionagainstmalariabyasimplechemoattenuatedpfspzvaccineregimeninarandomizedtrial
AT stephenlhoffman heterologousprotectionagainstmalariabyasimplechemoattenuatedpfspzvaccineregimeninarandomizedtrial
AT benjaminmordmuller heterologousprotectionagainstmalariabyasimplechemoattenuatedpfspzvaccineregimeninarandomizedtrial
AT petergkremsner heterologousprotectionagainstmalariabyasimplechemoattenuatedpfspzvaccineregimeninarandomizedtrial
_version_ 1721454652207136768